tiprankstipranks
Trending News
More News >
Silence Therapeutics (SLN)
NASDAQ:SLN
US Market

Silence Therapeutics (SLN) Income Statement

Compare
351 Followers

Silence Therapeutics Income Statement

Last quarter (Q4 2025), Silence Therapeutics's total revenue was £34.00K, a decrease of -99.86% from the same quarter last year. In Q4, Silence Therapeutics's net income was £-11.77M. See Silence Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 559.00K£ 43.26M£ 25.38M£ 21.66M£ 12.41M
Gross Profit
£ 344.00K£ 31.45M£ 15.06M£ 8.19M£ 4.96M
Operating Expenses
£ 90.10M£ 94.77M£ 64.66M£ 69.23M£ 50.77M
Depreciation and Amortization
£ 412.86K£ 593.00K£ 498.00K£ 596.00K£ 427.00K
EBITDA
£ -60.80M£ -48.99M£ -49.78M£ -60.44M£ -45.42M
Operating Income
£ -61.22M£ -63.32M£ -49.60M£ -61.04M£ -45.81M
Other Income/Expenses
£ 1.15M£ 18.86M£ -706.00K£ 11.39M£ -42.00K
Pretax Income
£ -88.60M£ -44.46M£ -50.31M£ -49.65M£ -45.86M
Net Income
£ -88.61M£ -45.31M£ -43.27M£ -50.33M£ -39.41M
Per Share Metrics
Basic EPS
£ -1.89£ -2.37£ -3.48£ -3.78£ -1.35
Diluted EPS
£ -1.89£ -2.37£ -3.48£ -3.78£ -1.35
Weighted Average Shares Outstanding
47.23M 15.42M 12.36M 10.73M 29.65M
Weighted Average Shares Outstanding (Diluted)
47.23M 15.42M 12.36M 10.73M 29.65M
Currency in GBP

Silence Therapeutics Earnings and Revenue History